Raymond James analyst Dane Leone reiterated a Strong Buy rating and $19.00 price target on Ocular Therapeutix (NASDAQ: OCUL)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Ocular Therapeutix (OCUL) PT Lowered to $17 at BofA Securities, PT $17March 3, 2025 11:48 AM